This inventor holds 3 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent. Top assignee: Enterobiome Inc.. Active years: 2022-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2026
Title: The Innovative Contributions of Joo-Hyun Shin
Introduction
Joo-Hyun Shin is a prominent inventor based in Seoul, South Korea. He has made significant strides in the field of probiotics, particularly in developing strains that can prevent or treat inflammatory and metabolic diseases. His work is paving the way for new therapeutic options in healthcare.
Latest Patents
Joo-Hyun Shin holds a patent for a novel EB-AMDK27 strain. This strain is designed to prevent or treat inflammatory diseases and metabolic diseases. The patent describes a pharmaceutical composition that includes the strain, a culture thereof, or a dried product thereof. Unlike traditional probiotics, which often have limited therapeutic effects, this next-generation probiotic strain demonstrates excellent efficacy in addressing these health issues.
Career Highlights
Joo-Hyun Shin is currently associated with Enterobiome Inc., where he continues to innovate in the field of probiotics. His research focuses on enhancing the therapeutic potential of probiotics, making them more effective in treating various health conditions.
Collaborations
He collaborates with notable colleagues, including Jae-Gu Seo and Do-Kyung Lee. Their combined expertise contributes to the advancement of probiotic research and development.
Conclusion
Joo-Hyun Shin's contributions to the field of probiotics are noteworthy, particularly his development of the EB-AMDK27 strain. His work holds promise for improving treatment options for inflammatory and metabolic diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile